Novavax Grows Presence at World Vaccine Congress 2023 and 33rd European Congress of Clinical Microbiology & Infectious Diseases
/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, will present data on its...
United States Erika Schultz Ali Chartan Novavax Inc Vaccine Technology Platform Award Prnewswire Novavax Inc
Source: prnewswire.com